推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 “2008、2009年左右，中藥飲片價(jià)格飛漲，市場(chǎng)比較混亂，出現(xiàn)了一些假劣藥品。”回憶起那幾年的光景，江蘇省中醫(yī)院藥學(xué)部主任姚毅顯得心有余悸?！拔覀冡t(yī)院的飲片吞吐量巨大，當(dāng)時(shí)每年的銷(xiāo)售額在2億元左右，所以不合格藥品退貨壓力很大，最嚴(yán)重時(shí)平均一天要退兩個(gè)批次。”
現(xiàn)如今，姚毅已把當(dāng)年的煩惱拋到九霄云外。2013年，原江蘇省衛(wèi)生廳與原貴州省衛(wèi)生廳簽署協(xié)議，開(kāi)展各項(xiàng)合作。江蘇省中醫(yī)院與貴州信邦制藥聯(lián)手，在貴州省建立中藥種植基地和飲片加工基地，為江蘇省中醫(yī)院提供保質(zhì)保量的中藥飲片?！艾F(xiàn)在完全不存在飲片退貨的問(wèn)題了，來(lái)的藥品肯定都是合格的?！闭f(shuō)到這里，姚毅喜形于色。
中藥基地的建設(shè)始于品種摸底，首先要確定貴州有哪些道地藥材品種，還要考慮哪些其他品種適合在貴州種植。梳理好品種后，同德公司又對(duì)貴州的種植區(qū)域進(jìn)行普查，對(duì)各個(gè)區(qū)域種植的藥材進(jìn)行檢測(cè)對(duì)比，最終在銅仁、遵義、安順等地確定了10個(gè)種植基地。每個(gè)基地在建設(shè)之前都由南京農(nóng)業(yè)大學(xué)中藥材研究所所長(zhǎng)郭巧生教授進(jìn)行基源鑒定。目前，這10個(gè)基地總占地面積達(dá)2萬(wàn)余畝，種植何首烏、太子參、天麻、杜仲、半夏、薏苡仁、茯苓等16種藥材。
這些藥材主要供江蘇省中醫(yī)院自用。該院主任中藥師朱玉鳳每個(gè)月都要趕赴貴州指導(dǎo)種植工作，姚毅也要三天兩頭到貴州看看。從種子的選擇、栽培到飲片的加工、炮制直到最終的物流運(yùn)輸，中藥材的種植—生產(chǎn)—使用全過(guò)程都處在專(zhuān)家的監(jiān)管之下，真正做到無(wú)縫銜接、嚴(yán)格把關(guān)。
